CLINICAL_TRIALS
trial_result
· 2015-10-12
Clinical Trial Update: A Study of Dalteparin Prophylaxis in High-Risk Ambulatory Cancer Patients [Phase 3]
Summary
A Phase 3 trial evaluating dalteparin prophylaxis in high-risk ambulatory cancer patients was terminated, with results posted in 2015.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Rochester | Conditions: Venous Thromboembolism, Pulmonary Embolism | Phase 3 | Status: TERMINATED | Results posted: 2015-10-12